Genomic Sequence Analysis Panel Of At Least 6 Genes Associated With Drug Metabolism in New Jersey

New Jersey Pricing in Context

In New Jersey, CPT code 81418 (Genomic Sequence Analysis Panel Of At Least 6 Genes Associated With Drug Metabolism) carries an average Medicare payment of $179.37 — 76% below the national benchmark of $758.80. 3 providers across the state submitted claims for this procedure in 2023, performing 50 total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New Jersey is $1,451.32, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drug/Toxicology Test procedures, the estimated commercial insurance price in New Jersey lands near $457.40, with self-pay cash prices typically around $533.64. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.